Editorial
doi: 10.1126/science.1117448.
Sending pharma better signals
- PMID: 16051753
- DOI: 10.1126/science.1117448
Item in Clipboard
Editorial
Sending pharma better signals
Science.
.
No abstract available
Comment in
-
Issues in bringing new drugs to the market.Science. 2005 Dec 2;310(5753):1425-6; author reply 1425-6. doi: 10.1126/science.310.5753.1425b. Science. 2005. PMID: 16322437 No abstract available.
-
Issues in bringing new drugs to the market.Science. 2005 Dec 2;310(5753):1425-6; author reply 1425-6. Science. 2005. PMID: 16329171 No abstract available.
-
Issues in bringing new drugs to the market.Science. 2005 Dec 2;310(5753):1425-6; author reply 1425-6. Science. 2005. PMID: 16329172 No abstract available.
Similar articles
-
Realizing two-tiered innovation policy through drug regulation.Stanford Law Rev. 2006 Feb;58(4):1221-50. Stanford Law Rev. 2006. PMID: 16685807 No abstract available.
-
Pharmaceuticals and medical devices: business practices. Issue brief.Issue Brief Health Policy Track Serv. 2012 Dec 31:1-36. Issue Brief Health Policy Track Serv. 2012. PMID: 23297448 No abstract available.
-
The ongoing regulation of generic drugs.N Engl J Med. 2007 Nov 15;357(20):1993-6. doi: 10.1056/NEJMp078193. N Engl J Med. 2007. PMID: 18003956 No abstract available.
-
Macro trends in pharmaceutical innovation.Nat Rev Drug Discov. 2005 Jan;4(1):78-84. doi: 10.1038/nrd1610. Nat Rev Drug Discov. 2005. PMID: 15688075 Review.
-
Key factors in the rising cost of new drug discovery and development.Nat Rev Drug Discov. 2004 May;3(5):417-29. doi: 10.1038/nrd1382. Nat Rev Drug Discov. 2004. PMID: 15136789 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
